Skip to content

IPure B1PC (clear), +16.50DRecalls & reported problems

Hoya Medical Singapore Pte. Ltd. · Foldable, posterior chamber intraocular lens (IOL), preloaded in an injector that automatically folds the lens as it is advanced, prior to insertion. Single use. · Class 3 · Implant

All models of IPure (24)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00886158017134), received between Jul 11, 2023 and Jul 11, 2023 — classified as 1 injury.

The most frequently reported specific device problem is “Sharp Edges” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Sharp Edges1

Patient problems

  • Capsular Bag Tear1
  • Failure of Implant1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryJul 11, 2023Sharp Edges; Sharp Edges

    INTRA-OPERATIVE COMPLICATIONS: POSTERIOR CAPSULE RUPTURE, EXPLANTATION WHILE INSERTING THE IOL IN THE BAG, THE LENS SEEMED UNSTABLE. AFTER INSPECTING THE POSTERIOR CAPSULE, IT WAS NOTED THAT THE IOL WAS THROUGH THE POSTERIOR CAPSULE. AT THAT TIME, SURGEON EXPLANTED THE IOL AND,PROCEEDED TO DO AN ANTERIOR VITRECTOMY. THE SURGEON USED ANOTHER IOL IN THE SULCUS AND THE POWER WAS CHANGED AS WELL. THE SURGERY WAS A SUCCESS. PATIENT HEALTH WAS NOT IMPACTED; PATIENT HAS RECOVERED AND IS FINE.

    Patient problems: Capsular Bag Tear; Failure of Implant

    MAUDE report 17297405 ↗

Other Intraocular Lens devices

All Intraocular Lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page